DJ Abbott Laboratories Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ slipped 1.32% to $126.32 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.25% to 6,829.37 and the Dow Jones Industrial Average rising 0.39% to 47,474.46.
This was the stock's second consecutive day of losses.
Abbott Laboratories closed 10.56% short of its 52-week high of $141.23, which the company reached on March 4th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 0.04% to $205.42, Pfizer Inc. $(PFE)$ fell 0.47% to $25.15, and Merck & Co. Inc. $(MRK)$ fell 0.79% to $101.03.
Trading volume (5.4 M) remained 946,911 below its 50-day average volume of 6.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 02, 2025 16:34 ET (21:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments